A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)
Clinical trial NCT01081652 · COMPLETED
Trial details
- NCT number
- NCT01081652
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.